IMA worried about AIFMD detail: IMA has responded to ESMA's call for evidence on Level 2 and 3 measures under the Alternative Investment Fund Managers Directive (AIFMD). It says any further unnecessary detail could be detrimental to investors. (Source: Press Release)

IMA comments on product intervention: IMA has commented on FSA's Discussion Paper on product intervention. It welcomes any changes which will bring other products and services within the same regulatory scrutiny as retail funds. (Source: Press Release)